华纳药厂
(688799)
| 流通市值：65.78亿 | | | 总市值：65.78亿 |
| 流通股本：1.31亿 | | | 总股本：1.31亿 |
| 报告期 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 713,712,049.73 | 336,233,032.74 | 1,412,949,151.44 | 1,069,303,325.98 |
| 营业收入 | 713,712,049.73 | 336,233,032.74 | 1,412,949,151.44 | 1,069,303,325.98 |
| 二、营业总成本 | 644,841,020.86 | 294,233,734.5 | 1,256,390,079.35 | 924,380,616.39 |
| 营业成本 | 278,083,767.97 | 123,601,457.63 | 542,148,384.27 | 402,683,130.21 |
| 税金及附加 | 8,321,043.4 | 3,105,201.57 | 25,776,310.19 | 18,089,062.56 |
| 销售费用 | 241,256,401.41 | 120,761,759.96 | 480,365,786.52 | 369,270,409.74 |
| 管理费用 | 48,230,141.92 | 23,245,747.77 | 66,892,928.37 | 47,079,440.34 |
| 研发费用 | 74,660,659.81 | 26,602,707.31 | 158,332,123.84 | 100,556,753.85 |
| 财务费用 | -5,710,993.65 | -3,083,139.74 | -17,125,453.84 | -13,298,180.31 |
| 其中:利息费用 | - | - | 17,209.8 | - |
| 其中:利息收入 | 5,976,128.81 | 3,190,026.23 | 16,836,850.45 | 13,679,371.81 |
| 三、其他经营收益 | | | | |
| 加:投资收益 | -3,181,624.95 | 535,543.58 | -18,662,074.42 | -11,400,345.34 |
| 资产减值损失(新) | -1,394,445.07 | -10,322.63 | -11,114,286.28 | -2,414,760.53 |
| 信用减值损失(新) | -748,268.2 | -959,927.35 | -1,293,469.92 | 337,550.33 |
| 其他收益 | 12,346,157.16 | 4,986,227.8 | 36,276,556.52 | 32,089,318.32 |
| 四、营业利润 | 75,892,847.81 | 46,550,819.64 | 161,765,797.99 | 163,534,472.37 |
| 加:营业外收入 | 52,058.73 | 1,350 | 22,044.43 | 19,543.6 |
| 减:营业外支出 | 722,901.46 | 13,987.64 | 111,505.34 | 111,505.34 |
| 五、利润总额 | 75,222,005.08 | 46,538,182 | 161,676,337.08 | 163,442,510.63 |
| 减:所得税费用 | 13,102,670.95 | 9,291,561.91 | 22,915,862.76 | 24,105,765.5 |
| 六、净利润 | 62,119,334.13 | 37,246,620.09 | 138,760,474.32 | 139,336,745.13 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 62,119,334.13 | 37,246,620.09 | 138,760,474.32 | 139,336,745.13 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 71,115,505.1 | 41,213,565.38 | 164,317,286.38 | 158,409,039.22 |
| 少数股东损益 | -8,996,170.97 | -3,966,945.29 | -25,556,812.06 | -19,072,294.09 |
| 扣除非经常损益后的净利润 | 59,153,920.81 | 35,802,291.2 | 138,260,921.98 | 134,512,501.29 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.54 | 0.44 | 1.75 | 1.69 |
| (二)稀释每股收益 | 0.54 | 0.44 | 1.75 | 1.69 |
| 九、综合收益总额 | 62,119,334.13 | 37,246,620.09 | 138,760,474.32 | 139,336,745.13 |
| 归属于母公司股东的综合收益总额 | 71,115,505.1 | 41,213,565.38 | 164,317,286.38 | 158,409,039.22 |
| 归属于少数股东的综合收益总额 | -8,996,170.97 | -3,966,945.29 | -25,556,812.06 | -19,072,294.09 |
| 公告日期 | 2025-08-30 | 2025-04-22 | 2025-04-22 | 2024-10-29 |
| 审计意见(境内) | | | 标准无保留意见 | |